Our biotech-powered serum continues to earn accolades in the world’s most advanced skincare market.

EXOGLO has been making waves in Japan — one of the most demanding and innovative skincare markets globally, where only the most effective, science-driven products thrive.

From showcasing at Cosme Week and fashion events to being featured in top-tier media, EXOGLO has become a trusted name among beauty insiders, editors, and clinical innovators. Our commitment has always been clear: drive meaningful results through science, not noise.

That dedication has resonated.

EXOGLO has steadily earned its place at the intersection of biotech and beauty — and the industry is paying attention.

One major highlight: Ginza magazine, one of Japan’s most respected fashion and lifestyle authorities, named EXOGLO among the “Top Serums to Watch in 2025.” This kind of recognition doesn’t come from hype — it comes from performance.

And now, we’re proud to share another milestone:

EXOGLO has received Poco’ce Magazine’s “Best Beauty Award” in the Stem Cell Serum category.

Poco’ce is a highly regarded voice in Japan’s beauty space, reviewing and awarding standout skincare products across categories twice a year. To be recognised in the stem cell category — one of the most competitive and innovation-driven — is a true honour.

Stem cell and exosome technologies are at the cutting edge of anti-aging skincare. Japan sets the global benchmark for scientific rigor, consumer expectations, and product efficacy — which makes this award especially meaningful.

EXOGLO continues to lead in one of the world’s most sophisticated skincare markets — and is proudly available globally.

To our growing community of skincare professionals, customers, and partners: thank you for championing a vision built on longevity, biotechnology, and results.

—
On behalf of Mesch,
Tommy Yan
Co-founder